New Ferritin-Based Nanomedicine for Targeted Delivery of Drugs Against Leukemia
| Date | 26th, Oct 2021 |
|---|---|
| Source | AZoNano - Nanotechnology Websites |
DESCRIPTION
Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences, Peking University and Zhujiang Hospital of Southern Medical University have developed a ferritin (Fn)-based nanomedicine for targeted delivery of arsenic (As) and efficient therapy against diverse leukemia types.